omega-n-methylarginine has been researched along with Metaplasia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, JC; Dave, B; Elemento, O; Ensor, JE; Ezzedine, NE; Gilcrease, MZ; Gonzalez, DD; Granados, S; Gross, SS; KarinaEtrovic, A; Li, X; Liu, ZB; Miller, KD; Mills, GB; Radovich, M; Sieglaff, DH; Wong, H | 1 |
1 other study(ies) available for omega-n-methylarginine and Metaplasia
Article | Year |
---|---|
Role of RPL39 in Metaplastic Breast Cancer.
Topics: Adenosine Deaminase; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Enzyme Inhibitors; Female; Humans; Kaplan-Meier Estimate; Metaplasia; Mice; Mutation Rate; Neoplasm Transplantation; Nitrates; Nitric Oxide Synthase Type II; Nitrites; omega-N-Methylarginine; Ribosomal Proteins; RNA-Binding Proteins; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; Survival Rate; Triple Negative Breast Neoplasms; Ubiquitin C | 2017 |